Ilika raises £0.9m in upsized retail offer

Ilika plc

Further to the announcement by the Company in respect of the Retail Offer dated 22 May 2025, Ilika plc (LON:IKA), has announced that, following the closing of the Retail Offer on the BookBuild platform on 28 May 2025, the Retail Offer was significantly oversubscribed. Accordingly, the Company has elected to increase scale of the Retail Offer to raise total gross proceeds of £0.9 million through the issue of 2,727,273 Retail Offer Shares at the Issue Price of 33 pence per share.

Consequently, it is anticipated that 9,884,017 Placing Shares, 81,819 Director Subscription Shares and 2,727,273 Retail Offer Shares resulting in a total of 12,693,109 New Ordinary Shares being issued in relation to the Fundraising. The total gross monies raised (before expenses) is approximately £4.2 million. The proceeds will be used as outlined in the retail offer announcement dated 22 May 2025 with the excess being proportionately assigned to further advance the commercial status of both of the Company’s product lines.

Allocations were made to existing Shareholders, applying the principles of soft pre-emption.  Given the significant demand, existing Shareholders received 100 per cent. of their soft pre-emptive allowance, when their order matched or exceeded their soft pre-emptive allowance. Where the order was greater than the soft pre-emptive allowance shareholders received c. 89.97 per cent of their additional demand1.

Other than where defined, capitalised terms used in this announcement have the meanings given to them in the Retail Offer Announcement.

Total Voting Rights

Following Admission of the New Ordinary Shares, the Company will have 180,802,175 Ordinary Shares in issue with the Company holding no Ordinary Shares in treasury. Therefore, the total number of voting rights will also be 180,802,175. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of Ilika Plc under the FCA’s Disclosure Guidance and Transparency Rules.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika: Building a bridge from niche batteries to mass market demand

Ilika is translating niche micro-battery expertise into a larger bet on scalable solid-state solutions for EVs and energy storage.

Ilika targets neuromodulation market with medical battery offering

Ilika is stepping directly into the medical-device market with its solid-state microbattery platform now featured at NANS 2026.

Ilika’s pack design shifts focus from cells to architecture

Ilika’s solid-state cells allowed a full battery pack redesign, cutting 100 kg, lowering cost, and extending range, without compromising safety.

Ilika CEO on Stereax production, Goliath progress, and growing market demand

Ilika's Graeme Purdy shares updates on the company’s advancements in solid-state battery technology, including Stereax manufacturing milestones, the upcoming release of Goliath P1.5 prototypes, and expanding customer interest across medical and industrial sectors.

Ilika Plc Customer Demand Soars as Stereax Production Ramps Up with Cirtec (Video)

Graeme Purdy, CEO of Ilika plc, outlines how solid-state Stereax batteries are entering production at Cirtec—with customer-ready units already on test. Applications span implanted sensors to orthodontics, and next-gen Goliath cells are primed for delivery by year-end.

Ilika reports advancing performance across Stereax and Goliath programmes

Ilika has outlined progress for the six months to 31 October 2025, including Stereax production qualification, Goliath prototype validation, and continued development supported by grant funding.

Search

Search